| scholarly article | Q13442814 |
| P2093 | author name string | Martha A Belury | |
| Min Tian | |||
| Michelle L Asp | |||
| Angela A Wendel | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 756-763 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice | |
| P478 | volume | 126 |
| Q64112425 | Adiponectin—Consideration for its Role in Skeletal Muscle Health |
| Q54946912 | Aerobic Exercise Training Attenuates Tumor Growth and Reduces Insulin Secretion in Walker 256 Tumor-Bearing Rats. |
| Q26784444 | B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia |
| Q48181999 | Branched-chain amino acids administration suppresses endurance exercise-related activation of ubiquitin proteasome signaling in trained human skeletal muscle. |
| Q38215557 | Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment |
| Q38290238 | Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options |
| Q35122201 | Cancer cachexia update in head and neck cancer: Pathophysiology and treatment. |
| Q64076285 | Cancer-Induced Reprogramming of Host Glucose Metabolism: "Vicious Cycle" Supporting Cancer Progression |
| Q40987037 | Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia |
| Q37625739 | Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma |
| Q33741091 | Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist. |
| Q93364919 | Diabetes pharmacotherapy and effects on the musculoskeletal system |
| Q55230769 | Drosophila as a Model System to Study Nonautonomous Mechanisms Affecting Tumour Growth and Cell Death. |
| Q90103137 | Drosophila as a Model for Tumor-Induced Organ Wasting |
| Q59798813 | Effect of Ninjin’yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice |
| Q38943695 | Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats |
| Q48520237 | Effects of metformin on insulin resistance and metabolic disorders in tumor-bearing rats with advanced cachexia |
| Q36340092 | Estrogen deprivation and excess energy supply accelerate 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in C3H/HeN mice |
| Q50851338 | Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle. |
| Q40580808 | Hypothalamic food intake regulation in a cancer-cachectic mouse model. |
| Q37042189 | Impaired regeneration: A role for the muscle microenvironment in cancer cachexia |
| Q36051080 | Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia |
| Q26827510 | Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia |
| Q35787728 | Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy |
| Q57014338 | Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites |
| Q38755264 | Maintaining a regular physical activity aggravates intramuscular tumor growth in an orthotopic liposarcoma model |
| Q35332991 | Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting |
| Q64979433 | Mitophagy in Cancer: A Tale of Adaptation. |
| Q90674899 | Molecular Insights into Muscle Homeostasis, Atrophy and Wasting |
| Q36179105 | Molecular and cellular mechanisms of skeletal muscle atrophy: an update. |
| Q39094397 | Molecular mechanism of sarcopenia and cachexia: recent research advances. |
| Q28068034 | Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans? |
| Q54448314 | Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? |
| Q51188121 | Muscle wasting in collagen-induced arthritis and disuse atrophy. |
| Q64229245 | Muscle wasting in patients with end-stage renal disease or early-stage lung cancer: common mechanisms at work |
| Q38587970 | Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches |
| Q39042463 | New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line. |
| Q38631222 | Novel investigational drugs mimicking exercise for the treatment of cachexia |
| Q34627257 | Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy |
| Q89030198 | Obesity Paradox and Smoking Gun: A Mystery of Statistical Confounding? |
| Q38895420 | Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. |
| Q40434933 | Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia |
| Q47743670 | Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model |
| Q41185732 | Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia |
| Q39093151 | Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice |
| Q34536058 | Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth |
| Q34200869 | Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1 |
| Q99710987 | T. gondii infection induces IL-1R dependent chronic cachexia and perivascular fibrosis in the liver and skeletal muscle |
| Q36028206 | The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse |
| Q36901945 | The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting |
| Q34031423 | The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse |
| Q37827379 | The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. |
| Q35828084 | The role of insulin resistance in the development of muscle wasting during cancer cachexia |
| Q37715719 | The role of vitamin D in skeletal and cardiac muscle function |
| Q28069390 | Understanding cachexia as a cancer metabolism syndrome |
| Q90814793 | Understanding cachexia in the context of metastatic progression |
| Q26852398 | Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment |
| Q42810913 | YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis. |
| Q45252295 | c9t11‐Conjugated linoleic acid‐rich oil fails to attenuate wasting in colon‐26 tumor‐induced late‐stage cancer cachexia in male CD2F1 mice |
Search more.